Angiotensin-receptor blockade in acute myocardial infarction - A matter of dose

被引：26

作者：

Mann, DL

Deswal, A

机构：

[1] Vet Affairs Med Ctr, Med Care Line, Houston, TX 77030 USA

[2] Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 349卷 / 20期

关键词：

D O I：

10.1056/NEJMe038163

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1963 / 1965

页数：4

共 10 条

[1] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Brenner, BM
Cooper, ME
de Zeeuw, D
Keane, WF
Mitch, WE
Parving, HH
Remuzzi, G
Snapinn, SM
Zhang, ZX
Shahinfar, S
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
[2] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
Cohn, JN
Tognoni, G
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1667 - 1675
[3] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
Dahlöf, B
Devereux, RB
Kjeldsen, SE
Julius, S
Beevers, G
de Faire, U
Fyhrquist, F
Ibsen, H
Kristiansson, K
Lederballe-Pedersen, O
Lindholm, LH
Nieminen, MS
Omvik, P
Oparil, S
Wedel, H
[J]. LANCET, 2002, 359 (9311) : 995 - 1003
[4] Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
Dickstein, K
Kjekshus, J
[J]. LANCET, 2002, 360 (9335) : 752 - 760
[5] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
McMurray, JJV
Östergren, J
Swedberg, K
Granger, CB
Held, P
Michelson, EL
Olofsson, B
Yusuf, S
Pfeffer, MA
[J]. LANCET, 2003, 362 (9386) : 767 - 771
[6] EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL
PFEFFER, MA
BRAUNWALD, E
MOYE, LA
BASTA, L
BROWN, EJ
CUDDY, TE
DAVIS, BR
GELTMAN, EM
GOLDMAN, S
FLAKER, GC
KLEIN, M
LAMAS, GA
PACKER, M
ROULEAU, J
ROULEAU, JL
RUTHERFORD, J
WERTHEIMER, JH
HAWKINS, CM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) : 669 - 677
[7] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Pfeffer, MA
McMurray, JJV
Velazquez, EJ
Rouleau, JL
Kober, L
Maggioni, AP
Solomon, SD
Swedberg, K
Van de Werf, F
White, H
Leimberger, JD
Henis, M
Edwards, S
Zelenkofske, S
Sellers, MA
Califf, RM
Aylward, P
Armstrong, P
Barvik, S
Belenkov, Y
Dalby, A
Diaz, R
Drexler, H
Ertl, G
Francis, G
Hampton, J
Harsanyi, A
Kvasnicka, J
Mareev, V
Marin-Neto, J
Murin, J
Myers, M
Nordlander, R
Opolski, G
Soler-Soler, J
Spac, J
Stefenelli, T
Sugrue, D
Van Gilst, W
Varshavsky, S
Weaver, D
Zannad, F
Aguilar, D
Alvarez, A
Al-Taweel, M
Anavekar, N
Finn, P
Lopez-Jimenez, F
Mercier, R
Lewis, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) : 1893 - 1906
[8] Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II
Pitt, B
Poole-Wilson, PA
Segal, R
Martinez, FA
Dickstein, K
Camm, AJ
Konstam, MA
Riegger, G
Klinger, GH
Neaton, J
Sharma, D
Thiyagarajan, B
[J]. LANCET, 2000, 355 (9215) : 1582 - 1587
[9] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Pitt, B
Remme, W
Zannad, F
Neaton, J
Martinez, F
Roniker, B
Bittman, R
Hurley, S
Kleiman, J
Gatlin, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) : 1309 - 1321
[10] ANGIOTENSIN-II - FORMING PATHWAYS IN NORMAL AND FAILING HUMAN HEARTS
URATA, H
HEALY, B
STEWART, RW
BUMPUS, FM
HUSAIN, A
[J]. CIRCULATION RESEARCH, 1990, 66 (04) : 883 - 890

← 1 →